Thalassemia Flashcards

1
Q

What type of disorder is thalassemia

A

genetic disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Disorder that results from abnormalities in the synthesis of the hemoglobin molecule contained in red blood cells

A

Thalassemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the inheritance pattern of thalassemia

A

AR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how many genes code for alpha chain

A

4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how many genes code for beta chains

A

2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

which gene is present in chromosome 16

A

alpha

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

which genes are present on chromosome 11

A

beta, gamma, delta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

the percentage of HbA

A

97%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

the percentage of Hb A2

A

2.5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

percentage of HbF

A

< 1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

alpha thalassemia mechanism

A

gene deletion chromosome 16

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

beta thalassemia mechanism

A

point mutation chromosome 11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

silent career with little signs

A

a-/aa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

–/aa

A

cis double deletion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

-a/-a

A

trans double deletion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is more common double deletion

A

cis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

–/-a

A

HbH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

–/–

19
Q

where is the point mutation in beta thalassemia

A

in control region

20
Q

when is beta thalassemia appear

A

when HbF gets substituted by HbA

21
Q

what indicates high Hb A2 and HbF

A

beta thalassemia

22
Q

serum fe in thalassemia

A

normal or increase

23
Q

ferritin in thalassemia

A

normal or elevated

24
Q

TIBC in thalassemia

A

normal or decreased

25
% sat in thalassemia
N or elevated
26
RBC in thalassemia
normal or elevated
27
MCV in thalassemia
decreased
28
MCH in thalassemia
decreased
29
RDW in thalassemia
normal
30
how do we diagnose Thalassemia
Diagnosis by molecular means if parents both known to be carriers of thalassemia
31
HbF protects infants with b thalassemia until which age
6 months
32
sickle cell beta thalassemia severity depends on
amount of b globe synthesis
33
when does a patient with b thalassemia be subjected to aplastic anemia
secondary to infection with parvovirus b19
34
diagnosis 6-24 months most probably is
beta thalassemia major
35
diagnosis 2-6 years most probably is
b/ a thalassemia minor or intermedia
36
coombs test in thalassemia is
negative
37
in thalassemia haptoglobin will be
decreased
38
confirmatory diagnostic studies
hb electrophoresis automated HPLC genetic studies (pcr based) bone marrow aspiration
39
patient with HbA2 >3.5%
b thalassemia minor
40
skull xray features
chipmunk face crew cut sign
41
Management in Thalassemia minor
-Usually no treatment required -Episodic folic acid supplementation may be indicated (e.g., during pregnancy, acute infections)
42
Management in thalassemia major and intermedia
1. Transfusion therapy (erythrocyte concentrates) -Indication (for transfusion-dependent thalassemias): Hb < 7 g/dL or marked clinical symptoms -Target: Hb > 9–10 g/dL 2. Surveillance and treatment of complications -Iron overload diseases: chelating agents, e.g., deferasirox, indicated when iron accumulation reaches toxic levels -Other complications: e.g., gallstones, asplenia, extramedullary hematopoietic pseudotumors
43
Management of thalassemia in select patients
1. Splenectomy 2. Potentially curative treatment -Stem cell transplantation: allogenic HSCT -Gene therapy